Mumbai, Feb 16: A 71-year-old woman who had remained almost unresponsive for over 45 days due to a rare neurological condition has regained speech and awareness following specialised treatment in the ...
LOS ANGELES -- The novel agent soticlestat flopped in a pair of phase III trials for rare seizure disorders, researchers reported here. Among Dravet syndrome patients in the SKYLINE trial, the median ...
Jacob Pellinen has received research support from the Department of Neurology at the University of Colorado School of Medicine, the Colorado Clinical and Translational Sciences Institute, NIH/NINDS, ...
Shobi Sivathamboo receives funding from the National Institutes of Health. She is affiliated with The International League Against Epilepsy SUDEP Task Force. When 20-year-old Disney Channel star ...
PHILADELPHIA — New open-label data from the expanded-access treatment program involving the cannabidiol Epidiolex (GW Pharma) show the median reduction in frequency of convulsive seizures after 3 ...
Recurrent seizures are debilitating and can sometimes, be fatal. The onset and presentation of seizures vary significantly among epilepsy patients. Of more than 25 categories of seizure presentations ...
Recurrent seizures are debilitating and can sometimes, be fatal. The onset and presentation of seizures vary significantly among epilepsy patients. Of more than 25 categories of seizure presentations ...
SEATTLE — Seizures are often scary to witness, but some seizures can also be silent and undetectable. These seizures are called non-convulsive seizures, and they can cause severe neurological damage. ...
ST. CLOUD, Fla. — Orlando Health St. Cloud Hospital has started using a portable artificial intelligence-powered electroencephalogram (EEG) device at patient’s bedsides to quickly detect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results